Neurocrine Bioscience buy Guggenheim
Start price
10.02.25
/
50%
€120.00
Target price
10.02.26
€157.98
Performance (%)
-2.54%
End price
11.02.26
€116.95
Summary
This prediction ended on 11.02.26 with a price of €116.95. With a performance of -2.54%, the BUY prediction by Guggenheim finished with a loss. Guggenheim has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -1.296% | -1.296% | 5.947% |
| iShares Core DAX® | -6.016% | -4.595% | 1.284% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.401% |
| iShares Nikkei 225® | -7.156% | -2.215% | 27.886% |
| iShares S&P 500 | -0.257% | -0.841% | 10.254% |
Comments by Guggenheim for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Guggenheim from $165.00 to $163.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.15
06.05.25
06.05.25
€146.09
06.05.26
06.05.26
3.51%
20:56
20:56
Stopped prediction by Guggenheim for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€140.30
02.08.24
02.08.24
€164.90
02.08.25
02.08.25
-21.03%
03.08.25
03.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€158.42
02.05.25
02.05.25
-26.05%
03.05.25
03.05.25